Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Obesity 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 31 Pemetrexed 28 Radiotherapy 22 Bevacizumab 21 Cisplatin 20 Gemcitabine 18 Paclitaxel 17 Erlotinib Hydrochloride 15 Docetaxel 12 Gefitinib 8 Nivolumab 6 Mastectomy, Segmental 6 Magnetic Resonance Spectroscopy 6 pembrolizumab 5 aflutinib 5 Radiosurgery 5 tislelizumab 4 Vinorelbine 4 Surgical Procedures, Operative 4 Specimen Handling 4 Sorafenib 4 Platinum 4 Metformin 4 Biopsy 4 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 4 sargramostim 3 apatinib 3 Taxes 3 Cetuximab 3 Anterior Temporal Lobectomy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma of Lung × Orlistat × Clear all

NCT06818955 2025-02-12

OOTER

Tongji Hospital

Phase 2 Not yet recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡